Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions

The American Journal of Cardiology
Rajendra H MehtaPrimary Angioplasty in Myocardial Infarction (PAMI) and the Controlled Abciximab and Device Investigation to Lower Late Angi

Abstract

Little information exists on the features that influence risk factors for death at 1 year among 30-day survivors of ST-elevation myocardial infarction (STEMI) that is treated with primary percutaneous coronary intervention (PCI). Accordingly, we examined 3,280 patients with STEMI who were enrolled in Stent-PAMI and CADILLAC trials, were treated with primary PCI, and survived >30 days after STEMI. Death at 1 year occurred in 74 patients (2.3%) who survived >30 days after their index STEMI. Patients who died at 1 year were more likely to be older and women and have lower body weight and greater prevalence of previous stroke. Similarly, the sum of ST elevations, 3-vessel or left anterior coronary disease, and final Thrombolysis In Myocardial Infarction grade <3 flow was higher, whereas left ventricular ejection fraction was lower among patients who died versus those who survived. The multivariate logistic regression model identified age >70 years (odds ratio [OR] 3.3 95% confidence interval [CI] 1.9 to 5.7), weight <80 kg (OR 1.9, 95% CI 1.1 to 3.6), any tachyarrhythmia during index hospitalization (defined as ventricular or supraventricular tachycardia that required treatment) (OR 2.4, 95% CI 1.2 to 4.8), number of diseased coron...Continue Reading

References

Mar 29, 2002·The New England Journal of Medicine·Gregg W StoneUNKNOWN Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators
Jun 10, 2004·JAMA : the Journal of the American Medical Association·Kim A EagleUNKNOWN GRACE Investigators

❮ Previous
Next ❯

Citations

Jun 7, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Spyridon LiosisUwe Zeymer
Feb 26, 2008·BMC Cardiovascular Disorders·Pieter A van der VleutenFelix Zijlstra
Nov 4, 2010·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Martin KreutzerOle Fröbert
Jan 22, 2013·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Karlis TrusinskisAndrejs Erglis
May 28, 2010·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Niels J W VeroudenRobbert J de Winter
Jul 7, 2009·The American Journal of Cardiology·Jang Hoon LeeUNKNOWN Korea Acute Myocardial Infarction Registry Investigators
Sep 26, 2006·American Heart Journal·Rajendra H MehtaMichael H Sketch
Apr 15, 2015·Journal of the Saudi Heart Association·Abdullah AlkhushailCharles Ilsely
Feb 12, 2013·International Journal of Cardiology·Sean van DiepenUNKNOWN APEX AMI Investigators
Nov 20, 2012·The American Journal of Cardiology·Matthijs A VeldersMartin J Schalij
Dec 18, 2013·Journal of Korean Medical Science·Hack-Lyoung KimUNKNOWN Other Korea Acute Myocardial Infarction Registry (KAMIR) and Korea Working Group on Myocardial Infarction (KorMI) Investigat
Sep 23, 2010·Circulation. Cardiovascular Interventions·Amanda StebbinsUNKNOWN Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI Investigators)
Jul 31, 2009·Coronary Artery Disease·Saman RasoulUNKNOWN Zwolle Myocardial Infarction Study Group
Nov 19, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Shiro TanakaUNKNOWN CREDO-Kyoto Investigators
Sep 17, 2011·The American Journal of Cardiology·William McLeish WilsonAndrew Edward Ajani
Apr 8, 2021·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Amir MikaeilvandArmin Attar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.